A share price of Sagimet Biosciences Inc [SGMT] is currently trading at $10.2, up 6.36%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The SGMT shares have gain 6.81% over the last week, with a monthly amount glided 3.76%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Sagimet Biosciences Inc [NASDAQ: SGMT] stock has seen the most recent analyst activity on July 24, 2025, when Canaccord Genuity initiated its Buy rating and assigned the stock a price target of $28. Previously, Oppenheimer started tracking the stock with Outperform rating on December 06, 2024, and set its price target to $30. On November 12, 2024, UBS initiated with a Buy rating and assigned a price target of $12 on the stock. Goldman downgraded its rating to a Neutral and decreased its price target to $6 on June 28, 2024. H.C. Wainwright initiated its recommendation with a Buy and recommended $32 as its price target on May 02, 2024. Leerink Partners started tracking with a Outperform rating for this stock on March 25, 2024, and assigned it a price target of $26. In a note dated August 08, 2023, TD Cowen initiated an Outperform rating.
Sagimet Biosciences Inc experienced fluctuations in its stock price throughout the past year between $1.73 and $10.43. Currently, Wall Street analysts expect the stock to reach $6 within the next 12 months. Sagimet Biosciences Inc [NASDAQ: SGMT] shares were valued at $10.2 at the most recent close of the market. An investor can expect a potential drop of -41.18% based on the average SGMT price forecast.
Analyzing the SGMT fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.39, Equity is -0.35 and Total Capital is -0.47. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.0.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 9.70 points at the first support level, and at 9.21 for the second support level. However, for the 1st resistance point, the stock is sitting at 10.84, and for the 2nd resistance point, it is at 11.49.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Sagimet Biosciences Inc [NASDAQ:SGMT] is 20.26. In addition, the Quick Ratio stands at 20.26 and the Cash Ratio stands at 9.01.
Transactions by insiders
Recent insider trading involved Happel David, President & CEO, that happened on Jul 21 ’25 when 65478.0 shares were sold. Chief Medical Officer, Martins Eduardo Bruno completed a deal on Jul 21 ’25 to sell 8277.0 shares. Meanwhile, General Counsel and CCO Rozek Elizabeth sold 10780.0 shares on Jul 21 ’25.
